Knell Michael Gunnar's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Mar 11, 2024
- Accession no.
- 0001127602-24-009396
- Filed
- Mar 11, 2024
- Trade date
- Mar 8, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $216.2K. It was filed 3 days after the trade.
This filing was later replaced by the amendment 0001127602-24-016791 (May 29, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Knell Michael GunnarCIK 0001543779 | Officer (CSVP&Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Common Stock | SSaleDisposed | −808 | $267.52 | −$216,156.16 | 7,024 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.